COMPARATIVE EFFECTIVENESS OF FIXED-DOSE FLUTICASONE PROPIONATE/SALMETEROL AND BUDESONIDE/FORMOTEROL COMBINATIONS IN ASTHMA: A US DATABASE ANALYSIS

被引:0
|
作者
Hamouda, Mohamed
Hanania, Nicola A.
Stanford, Richard H.
Rendon, Adrian
Gemicioglu, Bilun
Fritscher, Leandro
Boonsawat, Watchara
Khan, Shireen Quli
机构
关键词
D O I
10.1016/j.chest.2024.07.075
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:6461A / 6462A
页数:2
相关论文
共 50 条
  • [1] Fixed-dose fluticasone propionate/salmeterol (FP/SAL) and budesonide/formoterol (BUD/FOR) comparative effectiveness in moderate-severe asthma: US database analysis
    Hamouda, Mohamed
    Hanania, Nicola
    Stanford, Richard
    Rendon, Adrian
    Gemicioglu, Bilun
    Fritscher, Leandro
    Boonsawat, Watchara
    Khan, Shireen Quli
    Stanford, Richard
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [2] Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients
    Busse, William W.
    Shah, Shailen R.
    Somerville, Laura
    Parasuraman, Bhash
    Martin, Paula
    Goldman, Mitchell
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (06) : 1407 - 1414
  • [3] Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma
    Aalbers, R
    Backer, V
    Kava, TTK
    Omenaas, ER
    Sandström, T
    Jorup, C
    Welte, T
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (02) : 225 - 240
  • [4] Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma
    Price, David
    Hillyer, Elizabeth V.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (03) : 275 - 291
  • [5] COST-EFFECTIVENESS ANALYSIS OF GLYCOPIRRONIUM VERSUS TIOTROPIUM AND FIXED-DOSE COMBINATIONS (FORMOTEROL/BUDESONIDE AND SALMETEROL/FLUTICASONE) FOR COPD IN THE COLOMBIAN HEALTH CARE SYSTEM
    Giraldo, L. F.
    Karpf Benavides, E.
    Kraemer, M.
    Thuresson, P. O.
    VALUE IN HEALTH, 2014, 17 (03) : A175 - A175
  • [6] Inhaled Corticosteroids or Long-Acting β-Agonists Alone or in Fixed-Dose Combinations in Asthma Treatment: A Systematic Review of Fluticasone/Budesonide and Formoterol/Salmeterol
    Frois, Christian
    Wu, Eric Q.
    Ray, Saurabh
    Colice, Gene L.
    CLINICAL THERAPEUTICS, 2009, 31 (12) : 2779 - 2803
  • [7] EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma
    Dahl, Ronald
    Chuchalin, Alexander
    Gor, Dee
    Yoxall, Sally
    Sharma, Raj
    RESPIRATORY MEDICINE, 2006, 100 (07) : 1152 - 1162
  • [8] Budesonide/formoterol versus salmeterol/fluticasone for asthma in children: an effectiveness and safety analysis
    Jiang, Ping
    Zhao, Lanyu
    Yao, Zezhong
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (17) : 1283 - 1289
  • [9] Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation
    Ming, Simon Wan Yau
    Haughney, John
    Small, Iain
    Wolfe, Stephanie
    Hamill, John
    Gruffydd-Jones, Kevin
    Daly, Cathal
    Soriano, Joan B.
    Gardener, Elizabeth
    Skinner, Derek
    d'Alcontres, Martina Stagno
    Price, David B.
    RESPIRATORY MEDICINE, 2017, 129 : 199 - 206
  • [10] Comparative Resource Utilization in Medicaid-Eligible Patients With Asthma Treated With Fixed-Dose Fluticasone Propionate/Salmeterol or Fluticasone Propionate Monotherapy
    Stanford, Richard H.
    Riedel, Aylin A.
    Johnson, Jonathan C.
    Astry, Calvin L.
    CLINICAL THERAPEUTICS, 2010, 32 (10) : 1782 - 1793